The use of computed tomography (CT) for screening of targeted diseases is gaining much interest in the international medical community. An important aspect in the justification of screening with such a high dose examination is the radiation dose to the patient. The objective of this study was to perform a prospective assessment of the radiation dose and associated risk for deleterious effects from a CT screening programme. The excess lifetime risk of fatal cancer for various screening strategies was quantified by estimating the effective dose and by using age dependent mortality risk factors. The accrued data shows that the excess mortality risk due to screening with CT could be substantial. It ranges from 0.01% up to a few percent, strongly depending on the type and method of screening. Consequently, radiation dose and associate risk should be included as fundamental parameters for outlining and deciding a screening approach with CT. Recent technical developments, such as tube current modulation, are promising tools for dose reduction within the constraint of desired image quality.